Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Biological Clock Dysfunction in Optic Nerve Hypoplasia

Early Phase 1

Completed

Conditions: Biological Clock Dysfunction
Optic Nerve Hypoplasia

Interventions: Dietary Supplement: Melatonin
Dietary Supplement: Placebo Comparator

First Posted Date: 2009-01-21

Last Posted Date: 2020-09-25

Lead Sponsor: Yale University

Target Recruit Count: 100

Registration Number: NCT00825591

Locations: 🇺🇸
Children's Hospital of Los Angeles, Los Angeles, California, United States

Vorinostat in Combination With Palliative Radiotherapy for Patients With Non-Small Cell Lung Cancer

Phase 1

Completed

Conditions: Non-Small Cell Lung Cancer (NSCLC)

Interventions: Drug: Vorinostat
Radiation: Radiotherapy

First Posted Date: 2009-01-14

Last Posted Date: 2020-11-20

Lead Sponsor: Yale University

Target Recruit Count: 17

Registration Number: NCT00821951

Locations: 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States

Intra-observer and Inter-observer Variability With Dynamic Contour Tonometry.

Withdrawn

Conditions: Intraocular Pressure

Interventions: Device: Dynamic contour tonometry

First Posted Date: 2009-01-07

Last Posted Date: 2016-05-13

Lead Sponsor: Yale University

Registration Number: NCT00818233

Locations: 🇺🇸
Yale Eye Center, New Haven, Connecticut, United States

Pilot Study of a Raltegravir Based NRTI Sparing Regimen

Not Applicable

Completed

Conditions: HIV Infections
AIDS
Human Immunodeficiency Virus
Acquired Immune Deficiency Syndrome

Interventions: Other: Standard treatment regimen
Drug: Raltegravir
Drug: Atazanavir

First Posted Date: 2008-12-25

Last Posted Date: 2016-02-04

Lead Sponsor: Yale University

Target Recruit Count: 60

Registration Number: NCT00814879

Locations: 🇺🇸
Saint Raphael Healthcare System, New Haven, Connecticut, United States
🇺🇸
Waterbury Hospital, Waterbury, Connecticut, United States
🇺🇸
VA CT Healthcare Systems, West Haven, Connecticut, United States

and more 2 locations

Galantamine to Enhance Cognitive Behavioral Therapy for Cocaine Abuse

Phase 2

Completed

Conditions: Cocaine Dependence

Interventions: Drug: Galantamine
Behavioral: Computer Assisted Cognitive Behavioral Therapy (CBT)

First Posted Date: 2008-12-17

Last Posted Date: 2019-01-30

Lead Sponsor: Yale University

Target Recruit Count: 120

Registration Number: NCT00809835

Locations: 🇺🇸
Regional Network of Programs, Stratford, Connecticut, United States
🇺🇸
Kinsella Treatment Center (KTC), Bridgeport, Connecticut, United States

A Trial of Negative Ion Generation Versus Light-Emitting Diode Phototherapy for Seasonal Affective Disorder (SAD)

Phase 2

Completed

Conditions: Seasonal Affective Disorder

Interventions: Device: Light-emitting Photodiode light treatment device
Device: Negative Ion Generator

First Posted Date: 2008-12-17

Last Posted Date: 2013-03-06

Lead Sponsor: Yale University

Target Recruit Count: 106

Registration Number: NCT00809523

Locations: 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States
🇨🇦
St. John Regional Hospital, St. John, New Brunswick, Canada
🇨🇦
University of British Columbia, Vancouver, British Columbia, Canada

and more 5 locations

Transvaginal Appendectomy

Not Applicable

Completed

Conditions: Appendicitis

Interventions: Procedure: transvaginal appendectomy

First Posted Date: 2008-12-10

Last Posted Date: 2017-10-17

Lead Sponsor: Yale University

Target Recruit Count: 20

Registration Number: NCT00806429

Locations: 🇺🇸
Yale-New Haven Hospital, New Haven, Connecticut, United States

Integration of Buprenorphine Into HIV Clinical Settings - Primary Care Model (PCM)

Phase 4

Completed

Conditions: Opiate Addiction
Buprenorphine
HIV
Drug Dependence
Substance Abuse
Substance-related Disorders
Drug Abuse
Drug Addiction
Drug Use Disorders
Drug Use Disorder

Interventions: Other: Services remain dispersed; i.e., not centralized to one-location or provider.
Other: Services will be provided at one site

First Posted Date: 2008-11-26

Last Posted Date: 2015-07-24

Lead Sponsor: Yale University

Target Recruit Count: 60

Registration Number: NCT00798538

Locations: 🇺🇸
Yale AIDS Program, New Haven, Connecticut, United States

Pilot Trial of Naltrexone for Obesity in Women With Schizophrenia

Not Applicable

Completed

Conditions: Schizoaffective Disorder
Obesity
Schizophrenia

Interventions: Drug: Naltrexone 25mg
Other: Placebo

First Posted Date: 2008-11-19

Last Posted Date: 2016-10-06

Lead Sponsor: Yale University

Target Recruit Count: 24

Registration Number: NCT00793780

Locations: 🇺🇸
Connecticut Mental Health Center, New Haven, Connecticut, United States

Directly Observed Therapy for Community-Released HIV+ Prisoners

Not Applicable

Completed

Conditions: HIV/AIDS
Substance Abuse

Interventions: Behavioral: Directly administered antiretroviral therapy

First Posted Date: 2008-11-06

Last Posted Date: 2014-08-20

Lead Sponsor: Yale University

Target Recruit Count: 151

Registration Number: NCT00786396

Locations: 🇺🇸
Yale University-Yale Clinical Research, Hartford, Connecticut, United States
🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy